The reasons minority participants avoid clinical trials are well documented. Historical lack of consent, little diversity within the research team, and a percieved lack of relevance could all seem to push patients away. But researchers are working with community leaders, introducing trial navigators and working with doctors who have many patients from minority communities are all efforts that are being employed to turn the tide. A diverse trial population will ensure that the results more accurately reflect needs of the population as a whole. http://bit.ly/2rRMeXd
- What information can the donation of one patient’s tumor yield about metastasis?
- What is the iMPACT Program and how will it bring diversity to clinical trials?
- How is it possible that a great many promising cancer drugs create a problem for research and trials?
- Research Ethics Education a critical priority for WCGF: New Grant Opportunities Offered.
- How are physicians and researchers working to make clinical trials more diverse?